Abstract:The clay‐based 2D vermiculite nanosheets are developed as a self‐reinforcing chemodynamic nanoagent for efficient lung cancer treatment by targeting ferroptosis through depleting glutathione and upregulating lipid peroxidation levels. The ferrous oxidase hephaestin is the direct therapeutic target for 2D vermiculite nanosheets to fight against lung cancer cells which is also demonstrated. This therapeutic modality presents a multifunctional nanoplatform for ferroptosis‐based cancer chemodynamic therapy. The emerging chemodynamic therapy employs an iron‐based catalytic Fenton reaction to transform less‐reactive endogenous hydrogen peroxide within the tumor microenvironment (TME) into a highly toxic hydroxyl radical for killing cancer cells. However, the effective deployment of chemodynamic modality remains challenging, mired by a paucity of Fenton agents and overexpressed antioxidant glutathione (GSH) in cancer cells. Herein, a clay‐based 2D vermiculite nanosheet as a self‐reinforcing chemodynamic nanoagent for efficient lung cancer treatment is engineered. The engineered 2D vermiculite nanosheets are not only biocompatible with normal cells but also capable of regulating the TME through depleting GSH, which ameliorates the antioxidant activity of cancer cells. Meanwhile, GSH consumption results in increased intracellular reactive oxygen species content and enhanced lipid peroxidation level, thus inducing ferroptosis and augmenting chemodynamic cell‐killing efficacy. In particular, the ferrous oxidase hephaestin is the direct therapeutic target for 2D vermiculite nanosheets to fight against lung cancer cells. Systematic in vivo evaluations on a xenografted tumor model verify the favorable biosafety and effective tumor suppression capacity of the engineered 2D vermiculite nanosheets‐mediated chemodynamic tumor therapy by inducing desirable ferroptosis. Therefore, the developed vermiculite nanosheets represent the paradigm of 2D ferroptosis‐inducing nanomedicine for synergistic and efficient cancer treatment.

Layered Clay Minerals in Cancer Therapy: Recent Progress and Prospects (Small 34/2023)

Advances in the two-dimensional layer materials for cancer diagnosis and treatment: unique advantages beyond the microsphere

Research progress of calcium carbonate nanomaterials in cancer therapy: challenge and opportunity

Calcium Carbonate-Based Nanoplatforms for Cancer Therapeutics: Current State of Art and Future Breakthroughs

Recent Advances in Natural Nanoclay for Diagnosis and Therapy of Cancer: A Review

2D Catalytic, Chemodynamic, and Ferroptotic Vermiculite Nanomedicine

Two-dimensional layered nanomaterials for tumor diagnosis and treatment

Supramolecular Biomaterials for Cancer Immunotherapy

Calcium-based nanomaterials for cancer therapy

Functional two-dimensional MXenes as cancer theranostic agents

Two-dimensional nanomaterials induced nano-bio interfacial effects and biomedical applications in cancer treatment

Recent advances in cell membrane coated metal–organic frameworks (MOFs) for tumor therapy

Capturing functional two-dimensional nanosheets from sandwich-structure vermiculite for cancer theranostics

Metal–Organic Framework Nanomaterials as a Medicine for Catalytic Tumor Therapy: Recent Advances

Layer-by-Layer Nanoparticles for Calcium Overload in situ Enhanced Reactive Oxygen Oncotherapy

Multifunctional Liquid Crystal Nanoparticles for Cancer Therapy

Nanoclays in Medicine: A New Frontier of an Ancient Medical Practice

Design of metal-organic framework composites in anti-cancer therapies

Intelligent Design of Iron-Doped LDH Nanosheets for Cooperative Chemo-Chemodynamic Therapy of Tumors

Cell membrane-coated nanomaterials for cancer therapy

Lyotropic liquid crystalline 2D and 3D mesophases: Advanced materials for multifunctional anticancer nanosystems